Endometriosis and angiogenesis: On the tail of a riddle;Auf der spur eines rätsels: Angiogenese und endometriose

Geburtshilfe und Frauenheilkunde

Volumn 60, Issue 12, 2000, Pages 585-593

  Mueller, M D ^a   Dreher, E ^a   Taylor, R N ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ANGIOSTATIN; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; ICOSANOID; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; SEX HORMONE; SOMATOMEDIN B; SOMATOMEDIN C; THROMBOSPONDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CAPILLARY PROLIFERATION; CELL MIGRATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; IMMUNOCOMPETENT CELL; MACROPHAGE ACTIVATION; MENSTRUATION; PATHOGENESIS; PERITONEAL FLUID; REVIEW;

EID: 0034526680     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9542     Document Type: Review

References (113)

1. Thrombospondin-1
2. Angiopoietin-1 and Tie-2 are downregulated in dysfunctional uterine bleeding
3. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells
4. Zyklische Angiogenese-Prozesse im Ovar
5. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
6. Indirect angiogenic cytokines up-regulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
7. Leukocytes and resident blood cells in endometrium
8. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
9. Expression of basic fibroblast growth factor in normal human tissues
10. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment
11. Vascular endothelial growth factor/vas cular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
12. Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor
13. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
14. Iso lation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
15. Clinical relevance of the baboon as a model for the study of endometriosis
16. Influence of goserelin depot therapy on epidermal growth factor receptor expression in pelvic endometriosis
17. Endometriosis: Role of ovarian steroids in intiation, maintenance and suppression
18. Vascular endothelial growth factor (VEGF) in endometriosis
19. The unsuspected pelvic factor in the infertil ity investigation
20. Plas minogen activators in ectopic and uterine endometrium
21. The 16 K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells
22. The vascular en dothelial growth factor family of polypeptides
23. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction
24. The role of angiogenesis in tumor growth
25. Clinical applications of research on angiogenesis
26. Addressing tumor blood vessels
27. Expression of plate let-derived endothelial cell growth factor (PD-ECGF) related to angiogenesis in ovarian endometriosis
28. The insulin-like growth factor system in human peritoneal fluid: Its effects on endometrial stroma cells and its potential relevance to endometriosis
29. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua
30. Epidermal human factor stimulates vascular endothelial growth factor production by human malignant gliom cells: A model of glioblastoma multiforme pathophysiology
31. Control of pro liferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin
32. Adhesion of human endometrial fragments to peritoneum in vitro
33. Serum and peritoneal fluid levels of IGF I and II and insulinlike growth binding protein-3 in endometriosis
34. Retrograde menstruation in healthy women and in patients with endometriosis
35. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro
36. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
37. Tenascin is differentially expressed in endometrium and endometriosis
38. Immunological factors in endometriosis and endometriosis-associated reproductive failure
39. Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis
40. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium
41. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium
42. Endometrial endothelial ceils express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors
43. Interferon gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis
44. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis
45. The genetics of endometriosis
46. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis
47. Interleukin-8 as a macrophage-derived mediator of angiogenesis
48. Dioxin pollution and endometriosis in Belgium
49. Endometrial epithelial cells in peritoneal fluid during the early follicular phase
50. Induction of an angiogenic phenotype in endometriosis stromal cell cultures by lnterleukin-1β
51. Vascular endothelial growth factor in reproductive biology
52. Association of tumor necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma
53. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer
54. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
55. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
56. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
57. Expression of adrenomedullin in the endometrium of the human uterus
58. Synthesis and structure-activity profiles of A-homoestranes, the estratropones
59. Perivascular interleukin-8 messenger ribonucleic acid expression in human endometrium varies across the menstrual cycle and in early pregnancy decidua
60. Thymidine phosphorylase is angiogenic and promotes tumor growth
61. Expression of interleukin-1 (IL-1) beta messenger rebonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis
62. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis
63. Vascular Endothelial Growth Factor (VEGF) gene transcription is regulated by estrogen receptor in human endometrial cells
64. Neutmphils infiltrating the endometrium express Vascular Endothelial Growth Factor (VEGF): Potential role in endometrial angiogenesis
65. Platelet-derived growth factor promotes endometrial epithelial cell proliferation
66. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation
67. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro
68. Morphomettic study of the stromal vascularization in peritoneal endometriosis
69. The pattern of cytokine mRNA expression in ovarian endometriomata
70. Macrophage-conditioned media enhance endometrial stromal cell proliferation in vitro
71. Tansforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis
72. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
73. Steroid anti growth factor regulation of matrix metalloproteinase expression and endometriosis
74. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells
75. Expression of Tie2/Tek in breast turnout vasculature provides a new marker for evaluation of turnout angiogenesis
76. Vascular endothelial growth factor and the angiopoietins: Working together to build a better blood vessel
77. Peritoneal endometriotic lesions differentially express a haptoglobin-like gene
78. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis
79. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis
80. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
81. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: Correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis
82. Identification of rhesus macaques with spontaneous endometriosis
83. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis
84. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro
85. Peritoneal Endometriosis due to to the menstrual dissemination of endometrial tissue into the peritoneal cavity
86. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: Localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia
87. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)
88. Basic fibroblast growth factor: Peritoneal and follicular fluid levels and its effect on early embryonic development
89. Polypeptides synthe-sized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture
90. Polypeptides synthesized and released by rat ectopic uterine implants differ from those of the uterus in culture
91. Basic research in endometriosis
92. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
93. Antiangiogenic activity of tumor necrosis factor-alpha production regulators derived from thalidomide
94. Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis
95. Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: A model for endometriosis?
96. Evidence oft cell activation and potential cytokine action in human endometrium
97. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window
98. Antiproliferative effect of interferon-g in human endometrial epithelial cell in vitro: Potential local growth modulatory role in endometrium
99. Increased expression of comple ment component 3 in human ectopic endometrium compared with the matched eutopic endometrium
100. Angiogenesis and macrophage activation in endometriosis
101. Ovarian Steroids and Angiogenesis. Understanding Endometriosis
102. Genetic influences on endometriosis in an Australian twin sample
103. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis
104. Altered gene expression and secretion of interleukin-6 in stroreal cells derived from endometriotic tissues
105. Inhibition of in vitro angiogenesis by lymphotoxin and interferon gamma
106. Endometrial cell adhesion in an in vitro model using intact amniotic membranes
107. Human endometrial interleukin-6 (IL-6): In vivo messenger ribonucleic acid expression, in vitro protein production, and stimulation thereof by IL-1 beta
108. Whole explants of peritoneum and endometrium: A novel model of the early endometriosis lesion
109. The expression of soluble intercellular adhesion molecule-1 in endometriosis
110. Angiogenesis and tumor metastasis
111. Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines
112. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle